Compile Data Set for Download or QSAR
Report error Found 316 Enz. Inhib. hit(s) with all data for entry = 11381
TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793064BDBM793064(US20260049071, No. I-39)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793068BDBM793068(US20260049071, No. I-4)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793078BDBM793078(US20260049071, No. I-104)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793166BDBM793166(N-methyl-2-({3-[(E)-2-(5-{[(3S)-1-methylpyrrolidin...)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793080BDBM793080(US20260049071, No. I-42)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793081BDBM793081(US20260049071, No. I-86)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793060BDBM793060(US20260049071, No. I-38)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793135BDBM793135(US20260049071, No. I-3)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793135BDBM793135(US20260049071, No. I-3)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793072BDBM793072(US20260049071, No. I-40)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793091BDBM793091(US20260049071, No. I-2)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793141BDBM793141(US20260049071, No. I-103)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793142BDBM793142(US20260049071, No. I-120)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793166BDBM793166(N-methyl-2-({3-[(E)-2-(5-{[(3S)-1-methylpyrrolidin...)
Affinity DataIC50: 1nMAssay Description:Mutant BRAF WM266.4 Cells.More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793167BDBM793167(US20260049071, No. I-80)
Affinity DataIC50: 1nMAssay Description:Mutant BRAF WM266.4 Cells.More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793138BDBM793138(US20260049071, No. I-119)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793084BDBM793084(US20260049071, No. I-43)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793160BDBM793160(US20260049071, No. I-79)
Affinity DataIC50: 1nMAssay Description:The ability of Compound 102 to bind dopamine D2 receptors was measured in a cell-based assay. Dopamine D2 receptor cells were seeded in a half a blac...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793146BDBM793146(US20260049071, No. I-121)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793156BDBM793156(US20260049071, No. I-78)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793058BDBM793058(US20260049071, No. I-1)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793092BDBM793092(US20260049071, No. I-46)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793062BDBM793062(US20260049071, No. I-10)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793094BDBM793094(US20260049071, No. I-109)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793096BDBM793096(US20260049071, No. I-5)
Affinity DataIC50: 1nMAssay Description:This cell-based assay measures the ability of test compounds to inhibit the uptake of glycine by the glycine transporter type 1. Human placental chor...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793152BDBM793152(US20260049071, No. I-77)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793090BDBM793090(US20260049071, No. I-108)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793091BDBM793091(US20260049071, No. I-2)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793058BDBM793058(US20260049071, No. I-1)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793100BDBM793100(US20260049071, No. I-55)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793068BDBM793068(US20260049071, No. I-4)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793135BDBM793135(US20260049071, No. I-3)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793060BDBM793060(US20260049071, No. I-38)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793096BDBM793096(US20260049071, No. I-5)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793060BDBM793060(US20260049071, No. I-38)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793108BDBM793108(US20260049071, No. I-6)
Affinity DataIC50: 1nMAssay Description:This cell-based assay measures the ability of test compounds to inhibit the uptake of glycine by the glycine transporter type 1. Human placental chor...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793132BDBM793132(US20260049071, No. I-7)
Affinity DataIC50: 1nMAssay Description:This cell-based assay measures the ability of test compounds to inhibit the uptake of glycine by the glycine transporter type 1. Human placental chor...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793146BDBM793146(US20260049071, No. I-121)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793068BDBM793068(US20260049071, No. I-4)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793069BDBM793069(US20260049071, No. I-83)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793104BDBM793104(US20260049071, No. I-59)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793064BDBM793064(US20260049071, No. I-39)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793096BDBM793096(US20260049071, No. I-5)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793065BDBM793065(US20260049071, No. I-82)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793076BDBM793076(US20260049071, No. I-41)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793058BDBM793058(US20260049071, No. I-1)
Affinity DataIC50: 1nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793162BDBM793162(US20260049071, No. I-13)
Affinity DataIC50: 1nMAssay Description:Compounds (as well as stereoisomer(s) thereof and/or salt(s) thereof) were tested for CX3CR1 agonism in a cell based assay with fluorescent readout i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793070BDBM793070(US20260049071, No. I-101)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793072BDBM793072(US20260049071, No. I-40)
Affinity DataIC50: 1nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Beyang Therapeutics Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 793124BDBM793124(US20260049071, No. I-68)
Affinity DataIC50: 5.5nMAssay Description:The ability of compounds to down-regulate Estrogen Receptor (ER) numbers was assessed in a cell based immuno-fluorescence assay using the MCF-7 human...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/1/2026
Entry Details
US Patent

Displayed 1 to 50 (of 316 total ) | Next | Last >>
Jump to: